You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 8,116,527

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,116,527
Title:Using video-based imagery for automated detection, tracking, and counting of moving objects, in particular those objects having image characteristics similar to background
Abstract: A system and method to automatically detect, track and count individual moving objects in a high density group without regard to background content, embodiments performing better than a trained human observer. Select embodiments employ thermal videography to detect and track even those moving objects having thermal signatures that are similar to a complex stationary background pattern. The method allows tracking an object that need not be identified every frame of the video, that may change polarity in the imagery with respect to background, e.g., switching from relatively light to dark or relatively hot to cold and vice versa, or both. The methodology further provides a permanent record of an \"episode\" of objects in motion, permitting reprocessing with different parameters any number of times. Post-processing of the recorded tracks allows easy enumeration of the number of objects tracked with the FOV of the imager.
Inventor(s): Sabol; Bruce M. (Vicksburg, MS), Melton; R. Eddie (Vicksburg, MS)
Assignee: The United States of America as represented by the Secretary of the Army (Washington, DC)
Application Number:12/575,073
Patent Claims:see list of patent claims

Details for Patent 8,116,527

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial The United States of America as represented by the Secretary of the Army (Washington, DC) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.